clinical trial · NCT03632993
Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
Edematous Skincollagenase clostridium histolyticum (CCH)
brief summary
The study will evaluate the safety and effectiveness of different injection techniques of Collagenase Clostridium Histolyticum (CCH) for the treatment of adult women with mild, moderate or severe Edematous Fibrosclerotic Panniculopathy (commonly known as Cellulite).
started
Sep 18, 2018
primary completion
Jan 24, 2019
completion
Jan 24, 2019
last updated
Sep 7, 2023
official title
A Phase 2A, Open-Label Study Evaluating the Safety and Different Injection Techniques of CCH for the Treatment of Edematous Fibrosclerotic Panniculopathy (EFP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol